Local failure patterns after radical resection and adjuvant chemotherapy in patients with pN2 nonsmall-cell lung cancer: A retrospective analysis

被引:3
|
作者
Wang, Chenyu [1 ]
Li, Haixia [1 ]
Chen, Yongshun [2 ]
Ge, Hong [1 ]
机构
[1] Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan, Peoples R China
关键词
Nodal recurrence; nonsmall cell lung cancer; pN2; postoperative radiotherapy; VINORELBINE PLUS CISPLATIN; POSTOPERATIVE RADIOTHERAPY; TARGET VOLUME; STAGE-I; THERAPY; SURVIVAL;
D O I
10.4103/ijc.IJC_691_18
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The patterns of local failure in stage pN2 nonsmall-cell lung cancer (NSCLC) patients undergoing radical resection and adjuvant chemotherapy are controversial. Methods: The sites of local failure were compared in subgroups of patients with relevant clinicopathologic features (e.g., location and size of primary lesions). Results: Totally 75 patients with local failure after radical resection and adjuvant chemotherapy for pN2 NSCLC were included in the analysis. Thirty-seven (49.3%) patients had distant metastasis. The median duration from surgical resection to local failure was 11 months (range: 3-45 months). Sites with >= 10% failure rate in all subgroups based on the location of the primary lesions included 4R, 7, the ipsilateral hilum, and the stump. Additional sites with >= 10% failure rate included 2R, 2L, 4L, and 5 for lesions in the left upper lobe; 4L and 5 for lesions in the left lower lobe; and 2R and 3P for lesions in the right upper-middle lobe. Squamous cell carcinoma affected the stump failure rate compared to adenocarcinoma (56.3% vs. 18.0%, P = 0.003). Tumor diameter >= 5 cm affected the stump failure rate compared to tumor diameter < 5 cm (44.0% vs. 18.0%, P = 0.016). Skip N2 metastasis affected the ipsilateral hilum failure rate compared to nonskip N2 metastasis (7.5% vs. 31.4%, P = 0.008) Conclusions: For pN2 NSCLC patients undergoing radical resection and adjuvant chemotherapy, different lung lobes had different high-risk failure sites. Left lung cancer is prone to bilateral mediastinal lymph nodes recurrence, while right lung cancer mainly recurs with ipsilateral mediastinal lymph nodes. Moreover, the local failure patterns are influenced by pathological type, tumor size, and skip N2 metastasis.
引用
收藏
页码:323 / 329
页数:7
相关论文
共 50 条
  • [21] Impact of gender difference on adjuvant chemotherapy after radical resection in patients with non-small cell lung cancer.
    Yang, Lu
    Zhai, Xiaoyu
    Zheng, Qiwen
    Wang, Ziping
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Adjuvant chemotherapy based on biochemical modulation against pathological stage IIIA pN2 non-small cell lung cancer
    Otake, Y
    Tanaka, F
    Oyanagi, H
    Katakura, H
    Kawano, Y
    Takata, T
    Nakagawa, T
    Matsuoka, K
    Miyahara, R
    Yanagihara, K
    Li, M
    Isowa, N
    Bando, T
    Hasegawa, S
    Inui, K
    Wada, H
    LUNG CANCER: CURRENT TOPICS, 2001, : 55 - 58
  • [23] Is there role of adjuvant radiotherapy after complete resection of locally advanced nonsmall cell lung cancer?
    Jiang, Liyang
    Meng, Xiangjiao
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (01) : 44 - 50
  • [24] Efficacy of cascade-primed cell infusion as an adjuvant immunotherapy with concurrent chemotherapy for patients with nonsmall-cell lung cancer: A retrospective observational study with a 5-year follow-up
    Li, Hong
    Zhang, Zhen
    Duan, Xiaoran
    Maimela, Nomathamsanqa Resegofetse
    Yang, Shuangning
    Zhao, Xuan
    Huang, Jianmin
    Zhang, Yi
    CYTOTHERAPY, 2020, 22 (01) : 35 - 43
  • [25] Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma
    Stojsic, Jelena
    Stankovic, Tijana
    Stojkovic, Sonja
    Milinkovic, Vedrana
    Dinic, Jelena
    Milosevic, Zorica
    Milovanovic, Zorka
    Tanic, Nikola
    Bankovic, Jasna
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2015, 98 (01) : 27 - 32
  • [26] Bcl-2 protein and prognosis in patients with potentially curable nonsmall-cell lung cancer
    Silvestrini, R
    Costa, A
    Lequaglie, C
    Mochen, C
    Veneroni, S
    Leutner, M
    Ravasi, G
    VIRCHOWS ARCHIV, 1998, 432 (05) : 441 - 444
  • [27] Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer
    Cerfolio, Robert J.
    Bryant, Ayesha S.
    ANNALS OF THORACIC SURGERY, 2008, 86 (02): : 362 - 367
  • [28] EFFECT OF KRESTIN (PSK) AS ADJUVANT TREATMENT ON THE PROGNOSIS AFTER RADICAL RADIOTHERAPY IN PATIENTS WITH NONSMALL CELL LUNG-CANCER
    HAYAKAWA, K
    MITSUHASHI, N
    SAITO, Y
    TAKAHASHI, M
    KATANO, S
    SHIOJIMA, K
    FURUTA, M
    NIIBE, H
    ANTICANCER RESEARCH, 1993, 13 (5C) : 1815 - 1820
  • [29] Adjuvant therapy for resected pN2 non-small cell lung cancer: sequence is not all that matters
    Kokeny, Kristine E.
    Francis, Samual
    Tao, Randa
    Hitchcock, Ying J.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S2097 - S2099
  • [30] Pulmonary resection in patients with nonsmall-cell lung cancer treated with gamma-knife radiosurgery for synchronous brain metastases
    Yang, Seung-Yeob
    Kim, Dong Gyu
    Lee, Se-Hoon
    Chung, Hyun-Tai
    Paek, Sun Ha
    Kim, Joo Hyun
    Jung, Hee-Won
    Han, Dae Hee
    CANCER, 2008, 112 (08) : 1780 - 1786